Mavacoxib
Generic Name: mavacoxib
Dosage form: POWDER. Active ingredients: MAVACOXIB (1 kg/kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: MAVACOXIB (1 kg/kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Abrocitinib
abrocitinib
Janus Kinase Inhibitor [EPC]
11 DESCRIPTION CIBINQO (abrocitinib) tablets contain the free base of abrocitinib, a Janus kinase (JAK) inhibitor, for oral administration. Abrocitinib is a white to pale colored powder with the following chemical name: N- ((1 s ,3 s )-3-(methyl(7 H- pyrrolo[2,3- d ]pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide The solubility of abrocitinib in water is 0.04 mg/mL at 25ºC. Abrocitinib has a molecular weight of 323.42 g/mol and a molecular formula of C 14 H 21 N 5 O 2 S.
Drosera, Bryonia, Ipecacuanha, Cetraria Islandica, Coccus Cacti, Corallium Rubrum, Stannum Metallicum
drosera, bryonia, ipecacuanha, cetraria islandica, coccus cacti, corallium rubrum, stannum metallicum
Purpose Drosera 1C (Sundew)...............................................dry cough Arnica montana 3C (Leopard's Bane)..........................aches and pains, chest congestion Bryonia 3C (White Bryony).......................................painful cough Ipecacuanha 3C (Ipecac).........................................dry cough Cetraria islandica 1C (Iceland Moss)..........................cough with expectoration Coccus cacti 3C (Cochineal).....................................cough with expector
Guanfacine Er
guanfacine er
Guanfacine extended-release tablets, USP are a once-daily, extended-release formulation of guanfacine hydrochloride in a matrix tablet formulation for oral administration only. The chemical designation is N-amidino-2-(2,6-dichlorophenyl) acetamide monohydrochloride. The molecular formula is C9H9Cl2N3O·HCl corresponding to a molecular weight of 282.55 g/mol.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.